This week’s Research Ethics Roundup highlights ethical issues related to clinical trials studying the psychedelics, as well as moves toward making research more efficient, innovative, and transparent.
The Trip Treatment: Author and journalist Michael Pollan reports on the reemergence of research on psychedelics. In this article from The New Yorker, Pollan shares stories of participants and their experiences in clinical trials studying the psychedelic psilocybin.
Clinical-Trial Specialist Could Be Next FDA Chief: In this article from Nature, journalist Heidi Ledford provides background on Robert Califf, who was recently [...] Read more
This week’s Research Ethics Roundup explores ethical issues related to the conduct of research in resource-limited settings and reproducibility, as well as issues related to the development of Ebola treatments. Read on to find out more and discover what’s happening in the world of research ethics and oversight.
A Failed Trial in Africa Raises Questions About How to Test HIV Drugs: Donald J. McNeil Jr. reports on a clinical trial that was recently halted in South Africa, Zimbabwe, and Uganda in this article for The New York Times. The failed trial, which sought to evaluate [...] Read more
It has been a busy few weeks in the research oversight field with the release of a much anticipated Institute of Medicine report on data sharing and a new bill that seeks to overhaul drug and device development. Explore these and other stories below. HHS, Research Community Debate Informed Consent Policy: This piece from Kaiser Health News explores some of the various viewpoints surrounding the changes proposed by the Office for Human Research Protections in their “Draft Guidance on Disclosing Reasonably Foreseeable Risks in Research Evaluating Standards of Care." Read more
From new approaches to genetic research to changing conceptions of privacy, this week’s Research Ethics Roundup explores how advances in technology are changing the course of research.
Most Americans Would Share Health Data for Research: A recent NPR-Truven Health Analytics Health Poll saw a decline in the percentage of Americans willing to share their health information anonymously for research purposes. Fifty-three percent of respondents indicated that they were comfortable sharing anonymized health information, a 15 percent decline [...] Read more
U.S. Urged to Clarify Extent of Funding Moratorium on Risky Virus Research:
Researchers are pleading with the US government to clarify the details of a recent moratorium placed on funding projects that show potential risks due to the use of certain viruses. Concerns include confusion on the specific viruses and experiments covered by the new policy. A statement released by the National [...] Read more